Market Size of Fiducial Markers Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 4.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Fiducial Markers Market Analysis
The Fiducial Markers Market is expected to register a CAGR of 4% during the forecast period. This is attributing to the growing incidence of cancer, rising awareness on radiotherapy, increasing public and private funding in cancer research. As per Globocan, in 2018 the number of new cases of all type of cancers were approximately 18,078957 worldwide. The presence of a huge cancer population will be leading to the increasing demand for treatments thus promoting the growth of fiducial marker as these markers are used in radiotherapy procedure which is mandatory treatment procedures in most of the cancer patients. Moreover, growing awareness about radiotherapy techniques such as image-guided radiotherapy, stereotactic radiosurgery and intensity-modulated radiotherapy and rising adoption of radiotherapy for oncology treatment will increase the adoption of fiducial markers and thus propel the overall market. Furthermore, technological advancements associated with an advanced navigation system that will help in accurate placement of product and rising investments, funds by private and public organization in cancer research will trigger the revenue growth of fiducial markers and thus these are some more factors which will fuel the growth of the market in coming years. However, alternate treatment options and complication with the product implantation and usage may hamper the market to certain extent.
Fiducial Markers Industry Segmentation
As per the scope, Fiducial markers also referred to as fiducial are object which is placed in or near to tumor in the process of radiotherapy. This marker helps in pinpoint the tumor location with high accuracy and allows maximum radiation dosage to deliver resulting in accurate radiation dosage.
Fiducial Markers Market Size Summary
The Fiducial Markers Market is poised for steady growth, driven by the increasing incidence of cancer and the rising awareness and adoption of radiotherapy techniques. These markers play a crucial role in radiotherapy procedures, which are essential for cancer treatment, thereby boosting their demand. The market is further supported by public and private funding in cancer research and technological advancements in navigation systems that enhance the accuracy of marker placement. Despite potential challenges from alternative treatment options and complications related to marker implantation, the market is expected to expand, with metal-based markers, particularly gold markers, gaining traction due to their superior visibility and stability in imaging modalities.
North America is anticipated to maintain a significant share of the global Fiducial Markers Market, attributed to the high prevalence of cancer, a robust presence of key industry players, and substantial investment in research and development. The region benefits from advanced healthcare infrastructure and favorable reimbursement policies, which support the adoption of radiotherapy. The United States, in particular, holds a dominant position within North America. The market is moderately competitive, with major companies like IZI Medical Products, CIVCO Radiotherapy, and Medtronic leading the charge, ensuring continued innovation and growth in the fiducial markers sector.
Fiducial Markers Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Incidence of Cancer
-
1.2.2 Rising Awareness on Radiotherapy
-
1.2.3 Increasing Public and Private Funding in Cancer Research
-
-
1.3 Market Restraints
-
1.3.1 High cost of Fiducial Marker
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product
-
2.1.1 Metal-Based Markers
-
2.1.2 Polymer-Based Markers
-
2.1.3 Others
-
-
2.2 By Modality
-
2.2.1 MRI
-
2.2.2 CT/CBCT
-
2.2.3 Ultrasound
-
2.2.4 X-Ray
-
-
2.3 By Application
-
2.3.1 Lung Cancer
-
2.3.2 Breast Cancer
-
2.3.3 Prostate Cancer
-
2.3.4 Others
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Rest of World
-
-
Fiducial Markers Market Size FAQs
What is the current Fiducial Markers Market size?
The Fiducial Markers Market is projected to register a CAGR of 4% during the forecast period (2024-2029)
Who are the key players in Fiducial Markers Market?
IZI Medical Products, CIVCO Radiotherapy, Medtronic, QLRAD and Gold Anchor (Naslund Medical AB) are the major companies operating in the Fiducial Markers Market.
